These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunological function of the endothelial cell within the setting of organ transplantation. Taflin C; Charron D; Glotz D; Mooney N Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935 [TBL] [Abstract][Full Text] [Related]
7. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection. Naemi FM; Carter V; Kirby JA; Ali S Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649 [TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897 [TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated rejection in lung transplantation: myth or reality? Glanville AR J Heart Lung Transplant; 2010 Apr; 29(4):395-400. PubMed ID: 20338509 [TBL] [Abstract][Full Text] [Related]
10. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491 [TBL] [Abstract][Full Text] [Related]
11. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies. Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887 [TBL] [Abstract][Full Text] [Related]
12. Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts. Ronda C; Borba SC; Ferreira SC; Glotz D; Ianhez LE; Rodrigues H; Viggiani CS; Nahas W; David-Neto E; Castro MC; David Daisa SR; Kalil J; Panajotopoulos N Transplant Proc; 2011 May; 43(4):1345-8. PubMed ID: 21620126 [TBL] [Abstract][Full Text] [Related]
13. Endothelial cells as targets of allograft rejection. Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788 [TBL] [Abstract][Full Text] [Related]
14. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Jindra PT; Zhang X; Mulder A; Claas F; Veale J; Jin YP; Reed EF Transplantation; 2006 Jul; 82(1 Suppl):S33-5. PubMed ID: 16829793 [TBL] [Abstract][Full Text] [Related]
15. Relevance of MICA and other non-HLA antibodies in clinical transplantation. Sumitran-Holgersson S Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346 [TBL] [Abstract][Full Text] [Related]
16. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Paul LC; Muralidharan J; Muzaffar SA; Manting EH; Valentin JF; de Heer E; Kashgarian M Am J Pathol; 1998 May; 152(5):1209-23. PubMed ID: 9588890 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421 [TBL] [Abstract][Full Text] [Related]
19. [The role of immunologic response in chronic allograft rejection]. Boratyńska M Postepy Hig Med Dosw; 2003; 57(4):405-24. PubMed ID: 14601251 [TBL] [Abstract][Full Text] [Related]